Litcius/Paper detail

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer

Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi, Shoko Harada, Yuko Toyoda, Yugo Matsumura, Seiya Ichihara, Takeshi Imakura, Rikako Matsumoto, Ryohiko Ozaki, Ei Ogawa, Yutaka Morita, Atsushi Mitsuhashi, Yohei Yabuki, Hiroto Yoneda, Masaki Hanibuchi, Kayoko Hase, Eiji Takeuchi, Takashi Haku, Yasuhiko Nishioka

2024International Journal of Clinical Oncology8 citationsDOI

Topics & Concepts

MedicineSurgical oncologyImmunotherapyGranulocyte colony-stimulating factorStage (stratigraphy)OncologyLung cancerCancerCancer researchImmunologyInternal medicineChemotherapyBiologyPaleontologyLung Cancer Research StudiesImmune cells in cancerCancer Immunotherapy and Biomarkers
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer | Litcius